SCHEMBL21476552

SCHEMBL21476552

c1ccc(-c2cccc(-c3cc(-c4ccc(-c5cc6ccccc6o5)cc4)nc(-c4ccc5c(c4)oc4ccccc45)n3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.48
PLA2G4A P47712 5/20 0.48
PLA2G10 O15496 1/20 0.45
MAOB P27338 3/20 0.44
MAOA P21397 1/20 0.42
HPGD P15428 3/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
TNKS O95271 2/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
NPC1 O15118 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21480652 0.95 MAOB (0.48) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL23334474 0.94 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21476376 0.94 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21476622 0.92 PLA2G2A (0.51) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL23335209 0.90 CYP19A1 (0.43) PLA2G2APLA2G4AMAOBMAOAHPGD
SCHEMBL21028830 0.90 MEN1 (0.49) PLA2G2APLA2G4APLA2G10HPGDKDM4E
SCHEMBL21028838 0.90 MEN1 (0.49) PLA2G2APLA2G4APLA2G10HPGDKDM4E
SCHEMBL21029097 0.90 MEN1 (0.49) PLA2G2APLA2G4APLA2G10HPGDKDM4E
SCHEMBL21028971 0.90 MEN1 (0.49) PLA2G2APLA2G4APLA2G10HPGDKDM4E
SCHEMBL21029096 0.90 MEN1 (0.49) PLA2G2APLA2G4APLA2G10HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed
WO-2019198806-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 PLA2G2A 3064/4885PLA2G4A 4054/4885PLA2G10 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.